Solid Biosciences Inc Net debt/EBITDA
Quel est le Net debt/EBITDA de Solid Biosciences Inc?
Le Net debt/EBITDA de Solid Biosciences Inc est 1.53
Quelle est la définition de Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA des entreprises dans Health Care secteur sur NASDAQ par rapport à Solid Biosciences Inc
Que fait Solid Biosciences Inc?
solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.
Entreprises avec net debt/ebitda similaire à Solid Biosciences Inc
- Lennar a Net debt/EBITDA de 1.52
- Lennar a Net debt/EBITDA de 1.52
- Beyond Air a Net debt/EBITDA de 1.52
- First Defiance a Net debt/EBITDA de 1.53
- Resource Mining a Net debt/EBITDA de 1.53
- Baumart a Net debt/EBITDA de 1.53
- Solid Biosciences Inc a Net debt/EBITDA de 1.53
- Fuels a Net debt/EBITDA de 1.53
- Haidilao International a Net debt/EBITDA de 1.53
- WesCan a Net debt/EBITDA de 1.53
- HongGuang Lighting a Net debt/EBITDA de 1.54
- Sonoma Pharmaceuticals a Net debt/EBITDA de 1.54
- Surge Copper a Net debt/EBITDA de 1.54